Breaking News Instant updates and real-time market news.

QCOM

Qualcomm

$79.09

4.84 (6.52%)

, INTC

Intel

$58.57

2.17 (3.85%)

07:35
04/18/19
04/18
07:35
04/18/19
07:35

Unusual call flow in option market yesterday

Notable call activity was cited Wednesday in Qualcomm (QCOM), Intel (INTC), Freeport McMoRan (FCX), US Steel (X), Salesforce (CRM), Marvell (MRVL), Harley Davidson (HOG), Unum Group (UNM), Intra Cellular Therapies (ITCI), and Endurance (EIGI).

QCOM

Qualcomm

$79.09

4.84 (6.52%)

INTC

Intel

$58.57

2.17 (3.85%)

FCX

Freeport McMoRan

$14.18

0.04 (0.28%)

X

U.S. Steel

$16.66

-0.1 (-0.60%)

CRM

Salesforce

$155.31

-3.37 (-2.12%)

MRVL

Marvell

$24.87

0.86 (3.58%)

HOG

Harley-Davidson

$41.05

0.28 (0.69%)

UNM

Unum Group

$37.41

-0.12 (-0.32%)

ITCI

Intra-Cellular

$12.17

-0.52 (-4.10%)

EIGI

Endurance

$6.30

-0.2 (-3.08%)

  • 23

    Apr

  • 25

    Apr

  • 25

    Apr

  • 30

    Apr

  • 30

    Apr

  • 01

    May

  • 01

    May

  • 03

    May

  • 08

    May

  • 09

    May

  • 16

    May

  • 11

    Jun

  • 23

    Jun

  • 27

    Sep

QCOM Qualcomm
$79.09

4.84 (6.52%)

04/17/19
04/17/19
UPGRADE
Target $90

Outperform
Qualcomm upgraded to Outperform following Apple settlement at Evercore ISI
As previously reported, Evercore ISI upgraded Qualcomm (QCOM) to Outperform from In Line and raised its price target to $90 from $60 following the settlement with Apple (AAPL). Analyst C.J. Muse expects Qualcomm's earnings power to move "considerably higher" with incremental earnings of $2 from Apple and sees normalized earnings of $6.50-$7 into FY21 when including Huawei payments and buybacks. Muse said shares are "finally invertible again" now that the litigation is over combined with a clear path for the 5G ramp.
04/17/19
WELS
04/17/19
NO CHANGE
WELS
Market Perform
Intel exiting 5G smartphone modem business 'a positive,' says Wells Fargo
Wells Fargo analyst Aaron Rakers says that following the Apple (AAPL)-Qualcomm (QCOM) settlement announcement, Intel (INTC) announced its intention to exit the 5G smartphone modem business. The analyst views this as a positive for Intel. Rakers reiterates a Market Perform rating on Intel's shares.
04/17/19
04/17/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded to Overweight from Neutral at JPMorgan and to Outperform from In Line at Evercore ISI. 2. Domino's Pizza (DPZ) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst John Glass saying he thinks the stock's current price reflects 2-3% blended global same store sales growth over the next two years, which he views as too bearish based on its track record as a "best in class operator." 3. TSYS (TSS) upgraded to Buy from Neutral at Goldman Sachs with analyst James Schneider saying the company's new portfolios are driving revenue growth while improving margin expansion is driving earnings acceleration. 4. Omnicom (OMC) upgraded to Equal Weight from Underweight at Barclays. 5. Jones Lang LaSalle (JLL) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Jade Rahmani saying she sees an attractive entry point following the recent underperformance of the shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/18/19
DZBN
04/18/19
UPGRADE
DZBN
Buy
Qualcomm upgraded to Buy from Hold at DZ Bank
INTC Intel
$58.57

2.17 (3.85%)

04/17/19
KEYB
04/17/19
NO CHANGE
KEYB
Sector Weight
Intel 5G modem challenges a key factor leading to Apple settlement, says KeyBanc
KeyBanc analyst John Vinh notes that Qualcomm (QCOM) and Apple (AAPL) announced an agreement to dismiss all legal proceedings between the two companies worldwide, and says he believes challenges at Intel (INTC) on its 5G modem were a key factor leading to the settlement. The analyst also thinks this settlement likely will lead to a Huawei settlement, which could add another 80c in EPS for Qualcomm. While Vinh views the settlement as encouraging and as removing a major overhang for Qualcomm, he remains Sector Weight as he believes the economic benefit from the Apple settlement is largely reflected in the stock.
04/17/19
BARD
04/17/19
NO CHANGE
Target $10
BARD
Outperform
Lattice competitive landscape unchanged by Intel deal, says Baird
Shares of Lattice Semiconductor are trading lower on potential concerns related to smartphone procurement dynamics and the competitive landscape, Baird analyst Tristan Gerra tells investors in a research note. The analyst notes, however, that Lattice is de-emphasizing the smartphone market and no longer has content in Apple's (AAPL) new iPhones. Further, Intel's (INTC) acquisition of Omnitek does not change Lattice's competitive landscape, says Gerra. The analyst has an Outperform rating on Lattice Semiconductor with a $10 price target. The stock in afternoon trading is down 5%, or 62c, to $12.43.
04/17/19
KEYB
04/17/19
NO CHANGE
KEYB
Intel's plans to exit 5G Modem business not impacting 2019 outlook, says KeyBanc
KeyBanc analyst Weston Twigg says that on the heels of the Apple (AAPL)/Qualcomm (QCOM) deal, Intel (INTC) announced that it plans to exit the 5G smartphone modem business, which was originally expected to ramp in 2020 but was likely running behind schedule. The analyst believes that continued investment in its low-margin modem business made "little strategic sense" amid fab capacity constraints. Twigg does not expect this to impact Intel's 2019 outlook, though it is possible that it could improve the company's longer-term revenue and margin profile.
FCX Freeport McMoRan
$14.18

0.04 (0.28%)

02/19/19
SBSH
02/19/19
UPGRADE
Target $16
SBSH
Buy
Freeport McMoRan upgraded to Buy from Neutral at Citi
Citi analyst Alexander Hacking upgraded Freeport McMoRan (FCX) to Buy with a $16 price target. The analyst cites his firm's more constructive cooper market backdrop for the upgrade. Citi's global commodity team is bullish on copper, noting that exchange inventory is at 10 year lows and Chinese weakness appears to be turning, Hacking tells investors in a research note. The analyst believes copper equities have "significant rebound potential" with the stocks down 30%-40% year-to-date. Hacking this morning also double upgraded Southern Copper (SCCO) to Buy from Sell.
02/19/19
02/19/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. McDonald's (MCD) upgraded to Overweight from Equal Weight at Stephens with analyst Will Slabaugh saying McDonald's core U.S. business is accelerating and positioned to show upside to consensus estimates for Q1 and fiscal 2019. 2. PG&E (PCG) upgraded to Buy from Neutral at Citi with analyst Praful Mehta saying recent comments by California Governor Gavin Newsom indicate an "increasingly likelihood of legislative action." 3. PepsiCo (PEP) upgraded to Outperform from Neutral at Macquarie with analyst Caroline Levy saying new CEO Ramon Laguarta "moved decisively" to reset for sustained 4%-6% sales growth by stepping up marketing and capital spending. 4. Freeport McMoRan (FCX) upgraded to Buy from Neutral at Citi while Southern Copper (SCCO) was double upgraded to Buy from Sell. 5. Cosan (CZZ) upgraded to Overweight from Neutral at JPMorgan with analyst Lucas Ferreira saying the shares trade at an "excessive" 40% discount to net asset value, in the upper part of the 30%-40% range where the stock should be trading. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/25/19
JEFF
03/25/19
NO CHANGE
Target $18
JEFF
Buy
Jefferies sees 'significant trapped value' in shares of Freeport McMoRan
Jefferies analyst Christopher LaFemina says that over a two-plus year horizon, he sees "significant trapped value" within Freeport McMoRan that could be unlocked via a break-up or an acquisition of the company. In the shorter term, though, the Freeport investment case depends on two factors - the copper price, which should go higher, and the company's transition to its underground at Grasberg, LaFemina tells investors in a research note. He believes a successful transition at Grasberg "is critical but will be challenging." The analyst estimates Freeport's fair value to be $16.98 per share on a sum-of-the-parts basis. He keeps a Buy rating on the shares with an $18 price target.
02/13/19
02/13/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Freeport McMoRan (FCX) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Piyush Sood saying his firm's Metals & Mining team expects copper market tightness to emerge beginning in Q2, given falling global production, low visible inventories and improved demand from China and Freeport's earnings sensitivity to copper is still the highest among its peers. 2. DocuSign (DOCU) upgraded to Buy from Hold at Deutsche Bank with analyst Karl Keirstead saying that after speaking with four large e-signature customers, three using DocuSign and one using Adobe Sign, the analyst believes a "more constructive call on DocuSign shares is now warranted." 3. Bloom Energy (BE) upgraded to Outperform from Market Perform at Raymond James with analyst Pavel Molchanov saying shares are down about 36% since the IPO in July 2018, including a 24% drop since mid-January, the latter due in large part to selling pressure following lockup expiration. 4. Shopify (SHOP) upgraded to Outperform from Sector Perform at RBC Capital with analyst Ross MacMillan saying he anticipates the company to return to new merchant growth this year given its international opportunity and easier comps. 5. Myovant Sciences (MYOV) upgraded to Overweight from Equal Weight at Barclays with analyst Geoffrey Meacham saying his firm's women's health survey suggests a "robust potential market" for new treatment options for endometriosis and uterine fibroids. The analyst also raised his price target for the shares to $25 from $22. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
X U.S. Steel
$16.66

-0.1 (-0.60%)

04/11/19
04/11/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Chipotle (CMG) downgraded to Hold from Buy at Jefferies with analyst Andrew Barish saying after rallying 65% in Q1, Chipotle's valuation is full and reflects improved visibility for "powerful" same-store-sales and margin drivers. 2. Eli Lilly (LLY) downgraded to Neutral from Buy at Guggenheim with analyst Seamus Fernandez saying while he expects updates at the American Diabetes Association meeting to be broadly positive, he sees limited upside for the stock from current levels until Lilly's overall immunology portfolio and competition from Novo Nordisk's (NVO) semaglutide franchise is more fully understood. 3. U.S. Steel (X) downgraded to Underperform from Buy at BofA/Merrill with analyst Timna Tanners citing worse near-term U.S. market conditions than she anticipated. 4. Keurig Dr Pepper (KDP) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Dara Mohsenian saying she sees a negative risk-reward despite a "well telegraphed" Q1 earnings beat on strong pricing at heritage Dr. Pepper Snapple. 5. Waste Management (WM) downgraded to Hold from Buy at Stifel with analyst Michael Hoffman saying he factors in incrementally weaker paper prices and the impact of wet weather. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/09/19
04/09/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. SAP (SAP) downgraded to Hold from Buy at HSBC and to Neutral from Buy at UBS. 2. American Assets Trust (AAT) downgraded to Sector Weight from Overweight at KeyBanc with analyst Todd Thomas saying the stock has surpassed his previous $45 price target. 3. Ball Corp. (BLL) downgraded to Market Perform from Outperform at BMO Capital with analyst Mark Wilde saying that after an "impressive run," the stock is now trading at the upper end of its peer group range. 4. Charter (CHTR) downgraded to Neutral on valuation at Macquarie with analyst Amy Young saying shares reflect much of the operational and free cash flow potential and further multiple expansion hinges on its ability to set a consistent track record. 5. U.S. Steel (X) downgraded to Underperform from Neutral at Credit Suisse with analyst Curt Woodworth saying after performing deep dive analysis on U.S. Steel Flat Rolled segment, the analyst concludes the step-function rise in unit costs the past several years coupled with loss of automotive share suggests the company is in a weaker competitive position versus peers entering the "Sheet Tsunami" period in the U.S. from 2021-2022. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/11/19
BOFA
04/11/19
DOWNGRADE
BOFA
Underperform
U.S. Steel downgraded to Underperform from Buy at BofA/Merrill
04/11/19
BOFA
04/11/19
DOWNGRADE
Target $18
BOFA
Underperform
BofA double downgrades U.S. Steel to Underperform on worse U.S. conditions
BofA Merrill Lynch analyst Timna Tanners double downgraded U.S. Steel, to Underperform from Buy, citing worse near-term U.S. market conditions than she anticipated. Her channel checks indicate that recent price hikes have not stuck and that benchmark hot rolled coil prices have retreated to their yearly lows in recent days, Tanners tells investors. Given sharply lower scrap prices are pressuring U.S. steel prices, she sees limited catalysts and cut her price target for U.S. Steel shares to $18 from $31.
CRM Salesforce
$155.31

-3.37 (-2.12%)

04/05/19
OPCO
04/05/19
NO CHANGE
Target $127
OPCO
Outperform
Microsoft well positioned for digital transformations, says Oppenheimer
Oppenheimer analyst Tim Horan says he continues to believe Microsoft (MSFT) is well positioned for digital transformations. The company made several other announcements this week, including partnering with Adobe (ADBE) to compete with Saleforce (CRM), an IoT manufacturing platform with BMW (BMWYY), and more sales/marketing software to eCommerce companies, he says. Horan maintains an Outperform rating and $127 price target.
04/16/19
DADA
04/16/19
NO CHANGE
Target $75
DADA
Neutral
Blackbaud under threat from Salesforce nonprofit investment, says DA Davidson
DA Davidson analyst Rishi Jaluria kept his Neutral rating and $75 price target on Blackbaud (BLKB), which is down 4% in the pre-market, after the announcement by Salesforce (CRM) to combine its non-profit organization Salesforce.org with the parent. The analyst warns that the expected Salesforce investment increase in the nonprofit cloud space "could increase competitiveness against Blackbaud" longer term, even though he sees "enough differentiation" in the near term not to produce a significant change in competition.
04/16/19
JEFF
04/16/19
NO CHANGE
Target $189
JEFF
Buy
Salesforce remains a top large cap pick at Jefferies
Jefferies analyst John DiFucci says Salesforce remains a top large cap pick after the company said it will combine with Salesforce.org, an independent California public benefit corporation. As part of the transaction, Salesforce will pay $300M in cash for all shares of Salesforce.org. The analyst will change his model once the transaction closes and continues to believe the company remains well positioned to attain its long-term goals. DiFucci reiterates a Buy rating on Salesforce with a $189 price target.
04/09/19
NOMU
04/09/19
INITIATION
Target $300
NOMU
Neutral
Nomura Instinet starts 'true disruptor' Tesla with Neutral rating, $300 target
Nomura Instinet analyst Christopher Eberle initiated coverage of Tesla (TSLA) with a Neutral rating and $300 price target. The stock closed down 89c to $272.31. Tesla is a "true disruptor" of the automotive industry and its approach has "several moats," Eberle tells investors in a research note. The analyst, however, is cautious near term as Tesla navigates the "breakneck pace" of its global expansion. Eberle likens Tesla's position in electric vehicles and "Auto 2.0" to Salesforce (CRM) at the beginning of its software-as-a-service digital transformation era and its disruption of the way businesses bought and consumed software. Electric vehicle manufacturing and the selling of the cars are just the beginning of what CEO Elon Musk has in mind for Tesla, contends Eberle. He sees the company as "likely the foundation for automation of transportation."
MRVL Marvell
$24.87

0.86 (3.58%)

03/29/19
MZHO
03/29/19
NO CHANGE
Target $140
MZHO
Buy
Xilinx price target raised to $140 from $107 at Mizuho
Mizuho analyst Vijay Rakesh raised his price target for Xilinx (XLNX) to $140 from $107 following his trip to Asia and channel checks with the supply chain. Xilinx is a "significant leader" in 5G, with orders potentially up 50%-plus year-over-year in 2019 as the company is getting ~95% of 5G orders, Rakesh tells investors in a research note. The analyst also believes Xilinx has a "strong lead" over Intel (INTC) and Marvell Technology (MRVL). He reiterates a Buy rating on the shares.
03/08/19
OPCO
03/08/19
NO CHANGE
Target $26
OPCO
Outperform
Oppenheimer says structural bull thesis on Marvell 'intact' after Q4 results
Oppenheimer analyst Rick Schafer reiterated an Outperform rating and $26 price target on Marvell, saying his structural bull thesis is intact following the company's Q4 results. In a research note to investors, Schafer says management noted improvement in bookings over the past few weeks and sees the first quarter as the bottom for Storage and Networking. Shafer says Marvell is undershipping demand, particularly in storage as channel inventories clear. 5G infrastructure is a growth catalyst for late this year and adds that management is executing well through a challenging storage environment made worse by macro uncertainties and ongoing semi cycle correction.
03/08/19
CHLM
03/08/19
NO CHANGE
Target $19
CHLM
Hold
Marvell shares fully valued at current levels, says Craig-Hallum
Craig-Hallum analyst Christian Schwab maintained a Hold rating and $19 price target on Marvell following the company's Q4 results, telling investors in a research note that FY20 is set to be a challenging year, albeit with an expected bottom in Q1 and improvement through the course of the year. Schwab does believe the company is well positioned with growth prospects in both 5G and automotive, but believes shares remain fully valued at current levels until he sees more tangible traction of the company's growth prospects.
04/17/19
SBSH
04/17/19
NO CHANGE
Target $28
SBSH
Buy
Marvell price target raised to $28 from $22 at Citi
Citi analyst Atif Malik raised his price target for Marvell Technology Group to $28 from $22 citing improving storage fundamentals, increasing confidence in 5G momentum, and the company's "growing M&A appeal." Marvell is the best way of playing the "second wave" of 5G cycle spend as carriers' start to move to ASIC late this year, Malik tells investors in a research note. He keeps a Buy rating on the shares.
HOG Harley-Davidson
$41.05

0.28 (0.69%)

04/03/19
LBOW
04/03/19
NO CHANGE
LBOW
Neutral
Polaris Industries estimates cut after dealer checks at Longbow
Longbow analyst David MacGregor lowered his first half of 2019 estimates for Polaris Industries (PII) after his dealer checks showed that off-road vehicle sales faced multiple headwinds in Q1, including weather, price increases, and increasing financing rates. Also, dealers said there was an "underwhelming response" to Polaris' Spring Sales Event, according to MacGregor, who keeps a Neutral rating on the stock. MacGregor added that he expects Harley-Davidson (HOG) again lost share in Q1 to Polaris' Indian motorcycle line.
04/08/19
WELS
04/08/19
DOWNGRADE
WELS
Market Perform
Harley-Davidson downgraded to Market Perform from Outperform at Wells Fargo
04/08/19
WELS
04/08/19
DOWNGRADE
Target $41
WELS
Market Perform
Harley-Davidson risk/reward less attractive at current levels, says Wells Fargo
Wells Fargo analyst Timothy Conder downgraded Harley-Davidson to Market Perform from Outperform but raised his price target to $41 from $40, saying he believes risk/reward is now less attractive at current levels amid continued heavyweight motorcycle market weakness, tariff uncertainty and a "long" path to stabilization. Large heavyweight motorcycles, regardless of brand, remain challenged with ongoing new/used pricing and supply dynamics and a structural shift towards mid-size and smaller units, Conder says, adding that he believes Harley-Davidson's plans for mid-sized and small bikes, growing ridership and bringing in younger demographics to the brand and international expansion, collectively should provide a meaningful growth opportunity over time.
03/21/19
UBSW
03/21/19
NO CHANGE
Target $39
UBSW
Neutral
Harley-Davidson likely lost market share in past two months, says UBS
UBS analyst Robin Farley kept his Neutral rating and $39 price target on Harley-Davidson, saying that retail sales at the dealer level have likely declined in high single digits during January-February while the industry may have fared better. The analyst believes that although the seasonal comps were easier, weather issues around polar vortex and heavy rains in California may have "exacerbated the retail declines".
UNM Unum Group
$37.41

-0.12 (-0.32%)

01/09/19
LEHM
01/09/19
NO CHANGE
LEHM
Barclays downgrades Life Insurance sector to Neutral from Positive
Barclays analyst Jay Gelb downgraded the U.S. Life Insurance sector to Neutral from Positive because he doubts valuations will improve in a volatile environment. A sub-3% yield on 10-year Treasuries, a flat yield curve, declining equity markets and long-term care insurance risks are viewed as factors in the "substantial de-rating of life insurer valuations," Gelb tells investors in a research note. The analyst prefers the Property and Casualty sector based on its "lower beta and less exposure to a volatile macro environment." As part of the sector rating change, the analyst upgraded Ameriprise Financial (AMP) to Overweight from Equal Weight. He also continues to see value in Prudential (PRU), Unum Group (UNM) and Lincoln National (LNC). His Underweight rated names are Brighthouse Financial (BHF) and Torchmark (TMK).
05/03/18
RBCM
05/03/18
NO CHANGE
Target $44
RBCM
Sector Perform
Unum Group price target lowered to $44 from $54 at RBC Capital
RBC Capital analyst Mark Dwelle lowered his price target on Unum Group to $44 after its Q1 results, saying that while the earnings were in line, investors' concerns have turned to a high loss ratio in the quarter. The analyst keeps his Sector Perform rating despite the "attractive" valuation on the stock, noting that the overhang from the loss ratio will remain an overhang.
08/10/18
LEHM
08/10/18
DOWNGRADE
Target $42
LEHM
Underweight
Barclays double downgrades Brighthouse to Underweight on lack of catalysts
Barclays analyst Jay Gelb double downgraded Brighthouse Financial (BHF) to Underweight from Overweight and lowered his price target for the shares to $42 from $60. The analyst expects a "persistent low" return on equity profile for Brighthouse. Further, he sees a lack of potential catalysts now that the company has announced a share repurchase authorization faster than anticipated. Brighthouse's valuation is low, but other names in the space offer greater upside potential, Gelb tells investors in a research note. His Overweight-rated Life Insurance stocks include Prudential (PRU), Unum Group (UNM) and Principal Financial (PFG).
06/12/18
SBSH
06/12/18
NO CHANGE
Target $44
SBSH
Neutral
Unum Group price target lowered to $44 from $52 at Citi
Citi analyst Suneet Kamath lowered his price target for Unum Group to $44 citing greater long-term care uncertainty and potential for future related charges. While Unum's core group insurance business is attractive, it is already near peak returns, Kamath tells investors in a research note. He keeps a Neutral rating on the shares.
ITCI Intra-Cellular
$12.17

-0.52 (-4.10%)

12/12/18
ADAM
12/12/18
NO CHANGE
Target $31
ADAM
Buy
Intra-Cellular's NDA acceptance puts some investors fears to bed, says Canaccord
Canaccord analyst Sumant Kulkarni maintained a Buy rating and $31 price target on Intra-Cellular after the FDA accepted its new drug application for lumateperone for schizophrenia, and granted a PDUFA date of September 27, 2019, which paves the way for the company to potentially have a product on the market next year. In a research note to investors, Kulkarni says the NDA acceptance was expected, but the announcement puts some investor fears to bed. If approved, the analyst believes lumateperone could present a meaningful product for the treatment of schizophrenia given its relatively benign safety/side effect profile vs. the current standard of care.
11/13/18
LEER
11/13/18
INITIATION
Target $27
LEER
Outperform
Intra-Cellular initiated with an Outperform at Leerink
Leerink analyst Marc Goodman started Intra-Cellular with an Outperform and $27 price target as he initiates Neuroscience space with a Positive View. The analyst believes the Neuroscience sector is experiencing a "renaissance" as multiple new agents and mechanisms are coming up the pipeline across major therapeutic areas, the number of clinical studies is growing nicely, and the FDA is friendly to innovation in this space, companies are getting smarter about speed-to-market strategies and selecting niche sub-populations to focus on for initial product approvals, payer pushback on usage is much lower than in other categories, and physicians are enthusiastic about new agents. Regarding Intra-Cellular, Goodman believes that lumateperone should get approved for the treatment of schizophrenia and drive about $400M of peak sales for this indication in 2029.
12/12/18
12/12/18
NO CHANGE
Target $37

Outperform
Intra-Cellular price target raised to $37 from $35 at RBC Capital
As previously reported, RBC Capital analyst Brian Abrahams raised Intra-Cellular's price target to $37 from $35, saying the FDA NDA acceptance "meaningfully" de-risked the potential for lead drug lumateperone in its most advanced indication, schizophrenia. The analyst also believe shares significantly undervalue lumateperone's potential across neuropsych indications, with potential for bipolar depression data and schizophrenia approval to catalyze upside in 2019. He keeps an Outperform rating on the stock.
08/23/18
CANT
08/23/18
NO CHANGE
Target $32
CANT
Overweight
Intra-Cellular transferred with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Charles Duncan took over coverage of Intra-Cellular Therapies with an Overweight rating and $32 price target. The analyst sees a high probability of approval for lumateperone in schizophrenia.
EIGI Endurance
$6.30

-0.2 (-3.08%)

05/07/18
JEFF
05/07/18
NO CHANGE
Target $76
JEFF
Buy
GoDaddy price target raised to $76 from $66 at Jefferies
Jefferies analyst Brent Thill raised his price target for GoDaddy (GDDY) to $76 following a deep dive into the web presence market opportunity. The analyst thinks GoDaddy shares provide investors a "balanced profile" of double-digit revenue growth, margin expansion, and "significant" free cash flow generation, with valuation levels "still reasonable" despite outperformance. He calls a top mid-cap pick and reiterates a Buy rating on the name. Thill views Wix.com (WIX) as a "standout premium growth story," but with a tougher near-term setup. He keeps a Buy rating on the shares with an $86 price target. The analyst keeps an Underperform rating on Endurance (EIGI).
11/07/18
OPCO
11/07/18
DOWNGRADE
OPCO
Perform
Endurance downgraded to Perform from Outperform at Oppenheimer
Oppenheimer analyst Jason Helfstein downgraded Endurance International Group to Perform and removed his price target of $10. The analyst says the stock has reached his prior target price and he's unable to raise estimates or the target multiple. He believes investors are waiting for signs of revenue growth amid a "lack of 2019 visibility."
03/27/19
GSCO
03/27/19
UPGRADE
Target $7.5
GSCO
Neutral
Endurance upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Mark Grant upgraded Endurance International Group Holdings to Neutral from Sell with an unchanged price target to $7.50. The analyst cites valuation and few downside catalysts for the upgrade. He sees the stock's current risk/reward as fairly balanced.
01/09/19
JEFF
01/09/19
NO CHANGE
JEFF
Jefferies says be selective in Internet, cuts targets on Snap and Facebook
Jefferies analyst Brent Thill this morning cut his price targets on a handful of names in the Internet space. In a research note titled "2019 Playbook," the analyst also downgraded Booking Holdings (BKNG) and Redfin (RDFN) to Hold from Buy. Thill tells investors to selective in the space, and recommends buying Amazon.com (AMZN), Alphabet (GOOGL) and Intuit (INTU) in large cap, Match Group (MTCH), IAC (IAC) and GoDaddy (GDDY) in mid cap, and Wix.com (WIX) and Trade Desk (TTD) in small cap. He expects TripAdvisor (TRIP), Shutterstock (SSTK) and Shutterstock (EIGI) to underperform. Among his price target cuts were Buy-rated Expedia (EXPE) to $150, Buy-rated Facebook to $180, Hold-rated Snap (SNAP) to $7, Hold-rated Sonos (SONO) to $12, Hold-rated Twitter (TWTR) to $33 and Hold-rated Zillow Group (ZG) to $34.

TODAY'S FREE FLY STORIES

JCP

J.C. Penney

$0.93

0.022 (2.42%)

, DDS

Dillard's

$56.57

0.25 (0.44%)

13:29
05/25/19
05/25
13:29
05/25/19
13:29
Periodicals
Target stock triumphs in brutal week for retail, Barron's says »

Earnings season has been…

JCP

J.C. Penney

$0.93

0.022 (2.42%)

DDS

Dillard's

$56.57

0.25 (0.44%)

KSS

Kohl's

$51.11

-0.04 (-0.08%)

JWN

Nordstrom

$33.50

-0.31 (-0.92%)

M

Macy's

$21.00

-0.27 (-1.27%)

TGT

Target

$81.57

2.17 (2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

JPM

JPMorgan

$109.78

1.14 (1.05%)

, AKZOY

AkzoNobel

$0.00

(0.00%)

13:24
05/25/19
05/25
13:24
05/25/19
13:24
Periodicals
Microsoft, JPMorgan among dividend champions, Barron's says »

Among the companies that…

JPM

JPMorgan

$109.78

1.14 (1.05%)

AKZOY

AkzoNobel

$0.00

(0.00%)

XOM

Exxon Mobil

$74.12

0.33 (0.45%)

MSFT

Microsoft

$126.23

0.04 (0.03%)

CMWAY

Commonwealth Bank of Australia

$0.00

(0.00%)

SIEGY

Siemens

$0.00

(0.00%)

T

AT&T

$32.29

0.15 (0.47%)

RDS.A

Royal Dutch Shell

$63.29

0.84 (1.35%)

RHHBY

Roche

$0.00

(0.00%)

NVS

Novartis

$87.49

3.03 (3.59%)

BHP

BHP Group

$52.47

1.18 (2.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 29

    May

  • 29

    May

  • 31

    May

  • 03

    Jun

  • 03

    Jun

  • 03

    Jun

  • 05

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 11

    Jun

  • 12

    Jun

  • 20

    Jun

  • 23

    Jun

  • 16

    Jul

  • 24

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 02

    Sep

  • 04

    Nov

GM

General Motors

$35.13

0.01 (0.03%)

, TSLA

Tesla

$190.80

-4.7 (-2.40%)

13:19
05/25/19
05/25
13:19
05/25/19
13:19
Periodicals
Tesla stock in trouble, Barron's says »

Tesla (TSLA) stock is the…

GM

General Motors

$35.13

0.01 (0.03%)

TSLA

Tesla

$190.80

-4.7 (-2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

  • 05

    Jun

  • 11

    Jun

  • 01

    Aug

RNLSY

Renault

$0.00

(0.00%)

13:14
05/25/19
05/25
13:14
05/25/19
13:14
Periodicals
Renault stock may rally, Barron's says »

Shares of French auto…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMC

FMC Corporation

$70.88

-0.47 (-0.66%)

, DWDP

DowDuPont

$31.10

0.16 (0.52%)

13:11
05/25/19
05/25
13:11
05/25/19
13:11
Periodicals
DowDuPont spinoff a new agriculture stock, FMC safer bet, Barron's says »

The crop-protection and…

FMC

FMC Corporation

$70.88

-0.47 (-0.66%)

DWDP

DowDuPont

$31.10

0.16 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 25

    Jun

MGM

MGM Resorts

$25.55

0.19 (0.75%)

13:03
05/25/19
05/25
13:03
05/25/19
13:03
Periodicals
MGM Resorts looks like an attractive gambling play, Barron's says »

MGM Resorts (MGM) stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

PYPL

PayPal

$109.82

-0.09 (-0.08%)

, AXP

American Express

$119.52

1.07 (0.90%)

12:30
05/25/19
05/25
12:30
05/25/19
12:30
Periodicals
Big tech failed to dethrone credit cards, Barron's says »

Rather than being cut out…

PYPL

PayPal

$109.82

-0.09 (-0.08%)

AXP

American Express

$119.52

1.07 (0.90%)

MA

MasterCard

$251.40

1.57 (0.63%)

V

Visa

$162.72

1.2 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 03

    Jun

  • 05

    Jun

  • 06

    Jun

  • 11

    Jun

  • 25

    Jun

  • 13

    Nov

GOOG

Alphabet

$1,132.99

-7.56 (-0.66%)

, GOOGL

Alphabet Class A

$1,138.90

-5.98 (-0.52%)

07:20
05/25/19
05/25
07:20
05/25/19
07:20
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

GOOG

Alphabet

$1,132.99

-7.56 (-0.66%)

GOOGL

Alphabet Class A

$1,138.90

-5.98 (-0.52%)

MSFT

Microsoft

$126.23

0.04 (0.03%)

AMBA

Ambarella

$38.28

1.07 (2.88%)

ON

ON Semiconductor

$17.68

-0.235 (-1.31%)

NKE

Nike

$82.12

-0.51 (-0.62%)

ADDYY

Adidas

$0.00

(0.00%)

UAA

Under Armour

$23.54

0.075 (0.32%)

UA

Under Armour

$20.91

0.08 (0.38%)

FL

Foot Locker

$44.39

-8.455 (-16.00%)

VMC

Vulcan Materials

$126.28

1.25 (1.00%)

FLR

Fluor

$29.04

0.18 (0.62%)

ACM

Aecom

$31.56

-0.03 (-0.09%)

X

U.S. Steel

$13.63

-0.08 (-0.58%)

AKS

AK Steel

$2.00

-0.155 (-7.21%)

NUE

Nucor

$51.12

-0.27 (-0.53%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$12.85

0.11 (0.86%)

F

Ford

$9.83

-0.02 (-0.20%)

GM

General Motors

$35.13

0.01 (0.03%)

HMC

Honda

$25.45

0.175 (0.69%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$118.54

1.16 (0.99%)

VWAGY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 03

    Jun

  • 03

    Jun

  • 04

    Jun

  • 04

    Jun

  • 05

    Jun

  • 06

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 12

    Jun

  • 13

    Jun

  • 19

    Jun

  • 19

    Jun

  • 23

    Jun

  • 09

    Jul

  • 24

    Jul

  • 31

    Jul

  • 01

    Aug

  • 06

    Aug

  • 23

    Oct

  • 27

    Oct

UBER

Uber

$41.40

0.94 (2.32%)

17:49
05/24/19
05/24
17:49
05/24/19
17:49
Hot Stocks
Uber board director Ryan Graves intends to resign »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

APTO

Aptose Biosciences

$2.01

0.03 (1.52%)

17:46
05/24/19
05/24
17:46
05/24/19
17:46
Syndicate
Aptose Biosciences files for $40M at-the-market common stock offering »

Piper Jaffray and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

TRNX

Taronis Technologies

$0.48

0.004 (0.84%)

17:26
05/24/19
05/24
17:26
05/24/19
17:26
Syndicate
Breaking Syndicate news story on Taronis Technologies »

Taronis Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:25
05/24/19
05/24
17:25
05/24/19
17:25
Hot Stocks
U.S. Energy discloses Nasdaq notice regarding delayed 10-Q filing »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

17:22
05/24/19
05/24
17:22
05/24/19
17:22
Periodicals
Apple sued over allegedly selling users' iTunes data, Bloomberg says »

Apple is being sued by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SPCB

SuperCom

$1.17

-0.005 (-0.43%)

17:21
05/24/19
05/24
17:21
05/24/19
17:21
Hot Stocks
SuperCom discloses Nasdaq notice regarding delayed 20-F filing »

SuperCom received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:20
05/24/19
05/24
17:20
05/24/19
17:20
Hot Stocks
U.S. Energy receives noncompliance notice from Nasdaq »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:18
05/24/19
05/24
17:18
05/24/19
17:18
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:17
05/24/19
05/24
17:17
05/24/19
17:17
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$87.49

3.03 (3.59%)

, QGEN

Qiagen

$38.22

-0.255 (-0.66%)

16:57
05/24/19
05/24
16:57
05/24/19
16:57
Hot Stocks
Qiagen launches diagnostic for PIK3CA biomarkers in breast cancer »

Qiagen (QGEN) announced…

NVS

Novartis

$87.49

3.03 (3.59%)

QGEN

Qiagen

$38.22

-0.255 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 31

    May

  • 20

    Jun

  • 06

    Aug

AVH

Avianca

$3.96

0.91 (29.84%)

16:56
05/24/19
05/24
16:56
05/24/19
16:56
Periodicals
ANAC suspends flights, operations of Avianca Brasil, Reuters reports »

Brazil's ANAC said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

16:53
05/24/19
05/24
16:53
05/24/19
16:53
Periodicals
Apple acquires startup Tueo Health, CNBC reports »

Apple has bought Tueo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SHSP

SharpSpring

$16.37

-0.24 (-1.44%)

16:52
05/24/19
05/24
16:52
05/24/19
16:52
Syndicate
Breaking Syndicate news story on SharpSpring »

SharpSpring files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

CREG

China Recycling Energy

$0.48

0.005 (1.05%)

16:41
05/24/19
05/24
16:41
05/24/19
16:41
Syndicate
Breaking Syndicate news story on China Recycling Energy »

China Recycling Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FENC

Fennec

$3.88

(0.00%)

16:36
05/24/19
05/24
16:36
05/24/19
16:36
Conference/Events
Fennec management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 18

    Jun

TD

Toronto-Dominion

$56.66

0.65 (1.16%)

16:35
05/24/19
05/24
16:35
05/24/19
16:35
Syndicate
Breaking Syndicate news story on Toronto-Dominion »

Toronto-Dominion files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
05/24/19
05/24
16:30
05/24/19
16:30
Options
Preliminary option volume of 15.7M today »

Preliminary option volume…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.